Principal Securities’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.21M Buy
45,924
+1,385
+3% +$121K 0.05% 330
2026
Q1
$3.8M Buy
44,539
+26,307
+144% +$2.34M 0.06% 318
2025
Q4
$1.44M Buy
18,232
+3,220
+21% +$252K 0.02% 585
2025
Q3
$1.2M Buy
15,012
+772
+5% +$65.9K 0.02% 614
2025
Q2
$1.29M Buy
14,240
+3,863
+37% +$353K 0.02% 539
2025
Q1
$943K Buy
10,377
+55
+0.5% +$4.92K 0.02% 575
2024
Q4
$938K Buy
10,322
+1,800
+21% +$172K 0.02% 577
2024
Q3
$885K Buy
8,522
+1,376
+19% +$140K 0.02% 563
2024
Q2
$693K Buy
7,146
+1,163
+19% +$107K 0.02% 590
2024
Q1
$539K Buy
5,983
+1,385
+30% +$117K 0.02% 632
2023
Q4
$366K Buy
+4,598
New +$346K 0.01% 728

Other funds holding CL

Principal Securities's CL Position: Q2 2026 in Review

Principal Securities increased its Colgate-Palmolive (CL) stake by 3.1% in Q2 2026, buying an estimated $121K and bringing the position to 45,924 shares worth $4.21M. The position accounts for 0.05% of the portfolio, ranked #330.

Principal Securities first reported a position in CL in Q4 2023 and has held it in 11 quarters since. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Principal Securities held 45,924 shares of Colgate-Palmolive worth $4.21M as of Q2 2026.
  • Principal Securities bought 1,385 Colgate-Palmolive shares in Q2 2026, an estimated $121K.
  • Colgate-Palmolive made up 0.05% of Principal Securities's portfolio in Q2 2026, its #330 holding.
  • Principal Securities first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • 2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.